Houston space tech co. makes history with lunar lander launch

one small step

Intuitive Machines has successfully launched its lunar lander, which, once it lands on the moon, would be the first commercial vehicle to do so. Photo via Intuitive Machines

Houston-based Intuitive Machines just made one giant leap for mankind.

On February 15, the space exploration, infrastructure, and services company successfully launched its IM-1 mission Nova-C class lunar lander on SpaceX’s Falcon 9 rocket. The launch followed a one-day delay.

The lunar touchdown of the Odysseus spacecraft is set for February 22, according to The Washington Post.

“If all goes well … it will become the first American spacecraft to gently set down on the moon’s surface since the Apollo 17 moon landing in 1972,” The New York Times notes.

It also would be the first commercial vehicle to land on the moon.

The IM-1 mission lander launched from NASA’s Kennedy Space Center in Florida at 12:05 a.m. CST. The lunar lander reached its orbit about 48 minutes later, and made its first communication with Intuitive Machines’ mission operations center in Houston at 12:59 a.m. CST.

The Intuitive Machines IM-1 mission is the company’s first attempted lunar landing as part of NASA’s Commercial Lunar Payload Services initiative, a key part of NASA’s Artemis moon exploration efforts. The science and technology payloads sent to the moon’s surface as part of the initiative are aimed at gearing up for human missions and a sustainable human presence on the moon’s surface.

NASA is the primary customer for this mission, paying Intuitive Machines $118 million to take its payloads to the moon’s surface, including a stereo camera to observe the plume of dust kicked up during landing and a radio receiver to measure the effects of charged particles on radio signals, according to The Times. Also aboard is cargo such as a camera built by students at Embry-Riddle Aeronautical University in Daytona Beach, Florida, and the Moon Phases project by American artist Jeff Koons.

“We are keenly aware of the immense challenges that lie ahead,” Steve Altemus, co-founder, president and CEO of Intuitive Machines, says in a news release. “However, it is precisely in facing these challenges head-on that we recognize the magnitude of the opportunity before us: to softly return the United States to the surface of the Moon for the first time in 52 years.”

The liftoff of the IM-1 mission was targeted for a multiday launch window that opened at 11:57 p.m. CST on February 13. Intuitive Machines and SpaceX had concluded pre-launch testing on February 12.

“I feel fairly confident that we’re going to be successful softly touching down on the moon,” Altemus told The New York Times. “We’ve done the tests. We tested and tested and tested. As much testing as we could do.”

Last year, Intuitive Machines went public through a SPAC (special purpose acquisition company) merger with Inflection Point Acquisition Corp. The Houston company’s stock trades on the NASDAQ stock market. Following the launch of the lunar lander, Intuitive Machines saw a spike in its stock price on February 15.

From Your Site Articles
A Rice University study will consider how "design strategies aimed at improving civic engagement in stormwater infrastructure could help reduce catastrophic flooding." Photo courtesy of Kinder Institute

Rice University secures NSF support to look into Houston flooding

troubled waters

Houston will be the setting of a new three-year National Science Foundation-funded study that focuses on a phenomenon the city is quite familiar with: flooding.

Conducted by Rice University, the study will consider how "design strategies aimed at improving civic engagement in stormwater infrastructure could help reduce catastrophic flooding," according to a statement.

The team will begin its research in the Trinity/Houston Gardens neighborhood and will implement field research, participatory design work and hydrological impact analyses.

Rice professor of anthropology Dominic Boyer and Rice's Gus Sessions Wortham Professor of Architecture Albert Pope are co-principal investigators on the study. They'll be joined by Phil Bedient, director of the Severe Storm Prediction, Education and Evacuation from Disasters Center at Rice, and Jessica Eisma, a civil engineer at the University of Texas at Arlington.

According to Boyer, the study will bring tougher researchers from across disciplines as well as community members and even elementary-aged students.

"Our particular focus will be on green stormwater infrastructure—techniques like bioswale, green roofs and rain gardens—that are more affordable than conventional concrete infrastructure and ones where community members can be more directly involved in the design and implementation phases,” Boyer said. “We envision helping students and other community members design and complete projects like community rain gardens that offer a variety of beneficial amenities and can also mitigate flooding.”

Rice's Severe Storm Prediction, Education and Evacuation from Disasters Center, or SSPEED Center, is a leader in flood mitigation research and innovation.

In 2021, the center developed its FIRST radar-based flood assessment, mapping, and early-warning system based on more than 350 maps that simulate different combinations of rainfall over various areas of the watershed. The system was derived from the Rice/Texas Medical Center Flood Alert System (FAS), which Bedient created 20 years ago.

------

This article originally ran on EnergyCapital.

Virgin Trains may be speeding into Texas. Photo courtesy of Virgin Trains

Transportation company steers talk of high-speed trains between Houston, Austin, and San Antonio

ALL ABOARD?

You've likely heard of the proposed high-speed "bullet" train that would connect Houston and Dallas, as well as the proposed transportation-in-a-tube concept that would link Houston, Austin, Dallas, San Antonio, and Laredo.

Now, another possible alternative to planes, Amtrak trains, and automobiles has chugged into the picture.

Virgin Trains USA, a transportation startup that plans to trade its shares on the Nasdaq stock exchange, is exploring two high-speed routes in Texas — one tying together Houston, Austin, and San Antonio, and the other between Houston and Dallas. All four of those cities are plagued by ever-increasing traffic tie-ups.

There's no word yet on when these routes might take shape. At this point, they're merely ideas, and ahead of the company going public, officials at Virgin Trains are staying mum.

In all, Virgin Trains has outlined seven potential routes in the U.S. beyond what it already has on the drawing board.

"Our goal is to build railroad systems in North America that connect major metropolitan areas with significant traffic and congestion," the company says in a filing with the U.S. Securities and Exchange Commission.

Virgin Trains aims to tie together heavily populated cities separated by 200- to 300-mile distances that are "too long to drive, too short to fly." It wants to run the trains along existing transportation corridors — rail, highway or a combination of the two — "to cost-effectively build our systems, as opposed to developing entirely new corridors at potentially significantly higher costs."

If the Virgin name sounds familiar, it should. British billionaire Sir Richard Branson's Virgin Group is a minority investor in Virgin Trains, which already operates a South Florida route between Miami and West Palm Beach. West Palm Beach-to-Orlando and Orlando-to-Tampa routes also are in the works in Florida, in addition to a Los Angeles-to-Las Vegas route. Virgin's other transportation investments include airlines and space travel.

Jim Mathews, president and CEO of the Rail Passengers Association, says he's on board with the Branson-backed Virgin Trains venture — not as an "anti-Amtrak" move but as an advancement in U.S. passenger rail travel.

"Speaking from the experience of someone who spent almost his entire career watching Sir Richard innovate, invest, and take risks, I firmly believe this could be a real shot in the arm for passenger rail in the United States," Mathews writes on the association's website. "Like all entrepreneurs, Sir Richard isn't afraid to fail, and he has made a few bad bets in the past. But he's also made some very good ones, and has transformed not just travel but philosophies wherever he has gone."

------

This story originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston therapeutics innovator looks into GLP-1 drugs for Alzheimer’s treatment

drug discovery

Glucagon-like peptide 1, or GLP-1, agonists are all the rage right now thanks to drugs like Ozempic and Wegovy. Though they’re currently being prescribed for diabetes and weight loss, a Houston company reports that it may have found another use for GLP-1s.

Coya Therapeutics, a publicly traded clinical-stage biotechnology company, has filed intellectual property protection for a combination of its proprietary COYA 301 and GLP-1. Coya’s team believes that combining COYA 301, a low-dose interleukin-2 (IL-2) intended to enhance the anti-inflammatory function of regulatory T cells (Tregs), with GLP-1 could be a game-changer in the fight against Alzheimer’s disease.

How does GLP-1 amplify the positive results already noted for COYA 301? The company will soon release phase 2 data for IL-2 in patients with Alzheimer's. Through distinct mechanisms, the pair of drugs could synergistically combat inflammation. That means that neurodegenerative maladies such as Alzheimer’s are just the beginning. The drug combination could also fight autoimmune and metabolic conditions. This isn’t the first combination therapy for Coya — Coya 302 is a pairing of LD IL-2 and CTLA-4 Ig that has also racked up some success in human trials.

According to Coya’s CEO, Howard Berman, “We believe that combination immunotherapy approaches will evolve to play a meaningful role in treating complex immune-based diseases that are driven by a host of pathophysiologic mechanisms.”

He goes on to add that the company has already had success with targeting “multiple, independent, and non-overlapping immune pathways simultaneously” with COYA 302, a combination of COYA 301 and CTLA-4 Ig, commercially known as Abatacept. That pairing is currently being evaluated in numerous neurodegenerative disease models, such as Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s, and Parkinson’s diseases.

“We will continue to expand our portfolio with additional synergistic drug combinations with COYA 301,” Berman adds.

NASA, bp partner to share digital tech, expertise with new agreement

dream team

Houston-based energy company bp America is helping NASA boost U.S. space exploration efforts.

Under an agreement signed August 7, bp and NASA will share digital technology and technical expertise developed over several decades. The energy company says the deal will help advance energy production on earth, and will help advance exploration of the moon, Mars, and other planets.

For example, the agreement will enable bp and NASA to collaborate on an array of technologies. This includes digital models and simulations that let engineers and scientists visualize equipment in remote locations more than 7,000 feet underwater or millions of miles away on another planet.

The bp-NASA partnership evolved thanks to the Space Act Agreement. This agreement, part of the National Aeronautics and Space Act of 1958, allows NASA to work with companies, universities, and other entities to propel space exploration.

In a news release, Ken Nguyen, principal technical program manager at bp, says: “bp has built a proud legacy of technological innovation as we deliver the energy the world needs today while investing in the energy system of tomorrow. As NASA pursues a sustained presence on the moon and Mars, we see a unique opportunity for bp and NASA to work collaboratively on the forefront of digital technology that will cultivate further innovation in energy and space.”

Initially, bp and NASA will focus on developing standards, and expanding the capabilities of visualization and simulation models. Subsequent phases might include:

  • Exchanging practices surrounding safety, communication, artificial intelligence, and other aspects of remote operations.
  • Collaborating on renewable energy, such as hydrogen, solar, regenerative fuel cells, and high-capacity batteries.

“Both bp and NASA are custodians of deep technical expertise, working in extreme environments — whether that’s at the bottom of the ocean or on the moon,” says Giovanni Cristofoli, senior vice president of bp Solutions. “Sharing what we know with each other will help us solve complex engineering problems faster, meaning we can focus on keeping energy flowing safely and delivering higher margins with lower emissions.”

This won’t be the first time bp and NASA have teamed up. Offshore workers from bp have undergone underwater escape training at NASA's Neutral Buoyancy Laboratory, the astronaut training pool near Johnson Space Center. In addition, NASA has used bp’s Castrol lubricants for more than 60 years.

------

This article originally ran on EnergyCapital.

3 Houston innovators to know this week

who's who

Editor's note: Every week, I introduce you to a handful of Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes a Houston heart innovator, a cancer researcher, and space tech founder.

Dr. William Cohn, chief medical officer at BiVACOR

Why this Houston medical device innovator is pumped up for the first total artificial heart

Dr. William Cohn is the chief medical officer for BiVACOR, a medical device company creating the first total artificial heart. Photo via TMC

It's hard to understate the impact Dr. William Cohn has had on cardiovascular health as a surgeon at the Texas Heart Institute or on health care innovation as the director of the Center for Device Innovation at the Texas Medical Center. However, his role as chief medical officer of BiVACOR might be his most significant contribution to health care yet.

The company's Total Artificial Heart is unlike any cardiovascular device that's existed, Cohn explains on the Houston Innovators Podcast. While most devices are used temporarily for patients awaiting a heart transplant, BiVACOR's TAH has the potential to be a permanent solution for the 200,000 patients who die of heart failure annually. Last year, only around 4,000 patients were able to receive heart transplants.

"Artificial hearts historically have had bladders that ejected and filled 144,000 times a day. They work great for temporary support, but no one is suggesting they are permanent devices," Cohn says on the show. Read more.

Rebecca Richards-Kortum, director of the Rice360 Institute for Global Health Technologies

Rebecca Richards-Kortum, a Rice bioengineering professor and director of the Rice360 Institute for Global Health Technologies, is the lead PI on the project. Photo by Jeff Fitlow/Rice University

The Biden-Harris administration is deploying $150 million as a part of its Cancer Moonshot initiative, and a research team led by Rice University is getting a slice of that pie.

AccessPath is a novel, affordable, slide-free pathology system that helps surgeons determine if they have completely removed tumors during surgery. Rebecca Richards-Kortum, a Rice bioengineering professor and director of the Rice360 Institute for Global Health Technologies, is the lead PI on the project that is receiving up to $18 million over five years from the Advanced Research Projects Agency for Health (ARPA-H).

“Because of its low cost, high speed, and automated analysis, we believe AccessPath can revolutionize real-time surgical guidance, greatly expanding the range of hospitals able to provide accurate intraoperative tumor margin assessment and improving outcomes for all cancer surgery patients,” Richards-Kortum says. Read more.

Michael Suffredini, co-founder of Axiom Space

Axiom Space Co-founder Michael Suffredini is stepping down as CEO. Photo courtesy of Axiom Space

Houston-based space exploration company Axiom Space is searching for a new CEO. Co-founder Mike Suffredini stepped down effective August 9 as CEO. He cites unidentified personal reasons for his transition from CEO to company advisor. Suffredini remains a board member of Axiom Space.

Co-founder Kam Ghaffarian, the company’s executive chairman, is serving as interim CEO until Axiom Space taps Suffredini’s permanent successor. Read more.

View All Listings